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Dissemination of Mycobacteria to the Thymus Renders Newly
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Anto´nio Gil Castro,* Rui Appelberg,‡,x and Margarida Correia-Neves*
The ability of the thymus to generate a population of T cells that is, for the most part, self-restricted and self-tolerant depends to
a great extent on the Ags encountered during differentiation. We recently showed that mycobacteria disseminate to the thymus,
which raised the questions of how mycobacteria within the thymus influence T cell differentiation and whether such an effect
impacts host–pathogen interactions. Athymic nude mice were reconstituted with thymic grafts from Mycobacterium avium-
infected or control noninfected donors. T cells generated from thymi of infected donors seemed generally normal, because they
retained the ability to reconstitute the periphery and to respond to unspecific stimuli in vitro as well as to antigenic stimulation
with third-party Ags, such as OVA, upon in vivo immunization. However, these cells were unable to mount a protective immune
response against a challenge withM. avium. The observation that thymic infection interferes with T cell differentiation, generating
T cells that are tolerant to pathogen-specific Ags, is of relevance to understand the immune response during chronic persistent
infections. In addition, it has potential implications for the repertoire of T cells generated in patients with a mycobacterial
infection recovering from severe lymphopenia, such as patients coinfected with HIV and receiving antiretroviral therapy. The
Journal of Immunology, 2010, 184: 351–358.
S
everalmycobacterial species are important human pathogens,
causing a diverse set of diseases that are usually chronic and
progressive (1). The host immune response against these
pathogens depends, to a great extent, on the activation of infected
cells, mostly macrophages and dendritic cells (DCs), by mycobac-
teria-specific CD4+ T cells. IFN-g produced by mycobacteria-spe-
cific T cells plays a central role in this activation and, consequently,
in the control of mycobacterial infections (2). The increase in
Mycobacterium avium and Mycobacterium tuberculosis infections
observed in patients with HIV and low CD4+ T cell counts further
highlights the relevance of this cell population (3). Unlike M. tu-
berculosis, a primary human pathogen, M. avium is a common op-
portunistic bacteria responsible for localized or disseminated
infections, mainly in immune-suppressed individuals (4).
In addition to causing pathology at the site of entry (lung, gut, or
skin), mycobacteria are able to disseminate to several other tissues
and organs, such as pleura, meninges, and, to a lesser extent, bones
and joints (1). A few recent case reports showed the thymus to be
an additional site for mycobacterial dissemination (5–9). Using
the mouse as a model, we previously showed that the thymus is
a target for mycobacterial dissemination, regardless of whether the
route of infection used is i.v. or aerogenic (10). In both cases, the
bacterial load is initially undetectable or extremely low and in-
creases progressively for several weeks postinfection (10).
Because infection of the thymus with several pathogens is ac-
companied by premature thymic atrophy, associated or not with the
progressive lossofperipheralTcells, researchon the topichas focused
mostly on thymic cellularity (11). However, although disseminated
infection with a highly virulent strain ofM. avium is accompanied by
an intense premature thymic atrophy, this does not seem to be the case
when a less virulent strain of M. avium is used (12). The possibility
that T cell differentiation is maintained, despite the progressive col-
onization of the thymus with a given pathogen, prompted us to in-
vestigate towhat extentT cell differentiation is preservedandwhether
the newly generated T cells, whose differentiation occurred within
infected thymi, differ from those generated in noninfected thymi.We
observed that, although the production of new T lymphocytes is
maintained in infected thymi, these T cells do not mount a protective
immune response against the same pathogen in peripheral organs.
Materials and Methods
Mice and infection
C57BL/6 (wild-type [WT]), nude (B6.Cg-Foxn1nu/J), and TCRa2/2
(B6.129S2-Tcratm1Mom/J) mice were purchased from Charles River Labo-
ratories (Barcelona, Spain), Taconic Farms (Germantown, NY), and The
Jackson Laboratory (Bar Harbor, ME), respectively. All animal experi-
ments were performed in accordance with National and European Com-
mission guidelines for the care and handling of laboratory animals and
were approved by the National Veterinary Directorate and by the local
Animal Ethical Committee.
Eight- to 10-wk-old femalemicewere infected i.v.with 106CFUM.avium
strain 2447 (provided by Dr. F. Portaels, Institute of Tropical Medicine,
Antwerp, Belgium). Micewere sacrificed with isoflurane. The bacterial load
in the organs was determined as previously described (10).
Thymic transplant
Thymi were aseptically removed from TCRa2/2 mice and maintained in
DMEM (supplemented with 10% heat inactivated FCS, 10 mM HEPES,
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1 mM sodium pyruvate, 2 mM L-glutamine, 50 mg/ml streptomycin, and
50 U/ml penicillin) for 10–20 min until being transplanted under the
kidney capsule of nude mice (anesthetized with xylazine hydrochloride,
200 mg, and ketamine hydrochloride, 200 mg, administered i.v.).
Immunization
Mice were immunized subcutaneously on the back three times, at 1-wk
intervals, with 10 mg OVA (Sigma-Aldrich, St. Louis, MO), emulsified in
250 mg dimethyldioctadecyl ammonium chloride (Sigma-Aldrich) and
25 mg monophosphoryl lipid A (Sigma-Aldrich), prepared as specified
elsewhere (13). Mice were sacrificed 1 wk after the last immunization.
Immunofluorescence, histopathology, and image analysis
Sections (7 mm) of cryopreserved thymi were fixed in cold acetone,
washed, and blocked with 4% BSA in PBS 0.05% Tween. Tissues were
incubated overnight at 4˚C with purified Abs (rabbit anti-Mycobacterium
spp. polyclonal Ab [6398-0006, AbD, Serotec, Oxford, U.K.; an Ab raised
with extract from M. tuberculosis that reacts mainly with lipoara-
binomannan]; anti-keratin 5 [K5] [Abcam, Cambridge, U.K.]; anti-keratin
8 [K8] [Troma1, developed by P. Brulet and R. Kemler and obtained from
the Developmental Studies Hybridoma Bank, developed under the auspices
of the National Institute of Child Health and Human Development and
maintained by The University of Iowa, Department of Biology, Iowa City,
IA]; and anti-CD11c [N418] or anti-F4/80 [A3-1] [Serotec]). Secondary
Abs used were anti-rat IgG Alexa Fluor 594 or Alexa Fluor 488; anti-rabbit
IgG Alexa Fluor 488 (Molecular Probes, Eugene, OR); and biotinylated
anti-hamster IgG (Serotec) plus Pacific Blue-conjugated streptavidin
(Molecular Probes). In addition, mycobacteria were also detected by
auramine-rhodamine staining (AlphaTec Systems, Vancouver, WA) at the
end of the immunofluorescence protocol. Inducible NO synthase (iNOS;
clone M-19, Santa Cruz Biotechnology, Santa Cruz, CA) detection was
performed in paraffin-embedded liver sections, as described elsewhere (14).
Slides were visualized using an epifluorescence microscope (BX61
microscope with an Olympus DP70 camera), and images were analyzed
using Image J software (National Institutes of Health, Bethesda, MD). No
significant signal was observed in the negative controls (no Abs, no primary
Abs, and isotype controls); in the case of antimycobacteria staining, no
signal was observed in thymi from noninfected mice.
Analysis of lesions was performed in liver sections stained with he-
matoxylin and eosin. Using the320 objective, five random fields (in a total
area of 2.9 mm2) were photographed from one liver section per mouse.
Classification of the lesions was performed blindly.
Quantification of TCR rearrangement excision circles
Genomic DNA was isolated from thymi using TRIzol reagent. Quantifi-
cation of signal-joint TCR rearrangement excision circles (TRECs) was
performed by quantitative RT-PCR using the TCRA constant gene as an
endogenous reference [specific primers used were described elsewhere
(15)]. Quantitative RT-PCR reactions were performed on a CFX96 Real
Time System (Bio-Rad, Hercules, CA) using a QuantiTect SYBR Green
RT-PCR reagent kit (Qiagen, Hamburg, Germany). All melting curves
exhibited a single sharp peak.
Cell preparation, in vitro stimulation, and ELISPOT
Cell suspensions were prepared by gentle disruption of the organs between
two notched slide glasses. Es were lysed using a hemolytic solution (155
mM NH4Cl, 10 mM KHCO3, pH 7.2), and cells were resuspended in
supplemented DMEM.
Spleen cells were stimulated in vitro as described elsewhere (16). Stimuli
used were Con A (4 mg/ml), M. avium total extract proteins (4 mg/ml), or
a panel of m.w. fractions fromM. avium short-term culture filtrate (2mg/ml)
(details on the preparation can be found in Supplemental Fig. 1) (16). IFN-g
was quantified by ELISA (R4-6A2 and biotinylated AN18 were used as
capture and detection Abs, respectively; BD Biosciences, San Jose, CA).
Assay sensitivity was 20 pg/ml.
ELISPOTwas performed as described previously (14). The stimuli used
were 10 mg/ml mycobacteria epitope Ag85A241–260 (Metabion, Mar-
tinsried, Germany) (17) or OVA (Sigma-Aldrich).
Flow cytometry
Cells were labeled with Abs specific for CD3 (145-2C11), CD4 (RM4-5),
and CD8 (53-6.7, BioLegend, San Diego, CA). Cell acquisition was per-
formed on a FACSCalibur flow cytometer or on a FACSAria cell sorter
using Cell Quest software (BD Biosciences). Data were analyzed using
FlowJo software (Tree Star, Ashland, OR).
Statistical analysis
Differences among the means of experimental groups were analyzed with
the two-tailed Student t test. Differences with a p value #0.05 were
considered significant.
Results
Infected cells within the thymus are CD11c+
To evaluate the potential impact of mycobacterial dissemination to
the thymus onT cell differentiation, the identification of the infected
cells, aswellas their localization, isessential.Uponi.v. infectionwith
106 CFU ofM. avium, the thymus became progressively colonized
(Fig. 1A), with almost undetectable bacterial loads on day one, to
∼100 bacilli at 4 wk, and ∼105 viable bacteria at 24 wk post-
infection. We previously reported that during the first weeks of in-
fection the few bacteria that could be detected within the thymus
were mostly at the cortico-medullary region (10). As infection
progressed, bacteria were typically present within clumps of large
cells, mostly at the cortico-medullary region and within themedulla
(10). Using Abs specific for K8 (largely restricted to cortical epi-
thelial cells, with a small subset of K8+ cells within themedulla) and
K5 (largely restricted to the medulla, with a small subset of K5+K8+
cells at the cortico-medullary region and scattered in the cortex)
(18), we now confirm that the clumps of infected cells are typically
at the cortico-medullary andmedullary areas and less frequently are
within the cortex (Supplemental Fig. 2A–D).
All infected cells stained for CD11c (Fig. 1B–E) and consisted
of two populations. The majority were CD11c+F4/80+ (Fig. 1B),
a phenotype consistent with foamy macrophages (19, 20). To
a lesser extent, bacteria were detected within CD11c+F4/802 cells
(Fig. 1C), a phenotype compatible with DCs. As described pre-
viously (21), a weak staining was observed throughout the cyto-
plasm of infected cells when antimycobacteria Abs were used
(Fig. 1B, 1C). This has been attributed to mycobacterial envelope
material present in the phagosomes of infected cells (21).
Epithelial cells do not seem to be a target forM. avium infection,
because no infected cells expressed K8 (Fig. 1D), K5 (Fig. 1E), or
epithelial cell adhesion molecule (Supplemental Fig. 1E).
Because DCs within the thymus are known to play an important
role in thymocyte selection processes (22–26), the observation that
M. avium-containing DCs are present in these areas suggests that
thymic infection might influence T cell differentiation.
T cells generated in mycobacteria-infected thymi are unable to
control bacteria proliferation in the periphery
Accelerated thymic atrophy, which is accompanied by reduced or
abrogated T cell differentiation, has been frequently reported
during systemic infections (11). This is well known in humans
infected with HIV (27) and has been shown in several animal
models of infection (11, 12). The mycobacterial infection used in
this study did not result in altered total thymic cell number up to
22 wk postinfection (Fig. 2A). Only minor differences were de-
tected, at late time points, in the proportion of the four main
thymocyte populations (double negative CD42CD82CD32, dou-
ble positive CD4+CD8+CD3low/2, CD4 single positive CD4+
CD82CD3+, and CD8 single positive CD42CD8+CD3+) (Fig. 2B).
Moreover, no differences were detected in the amount of TRECs
up to 30 wk postinfection (Fig. 2C). These results suggest that
thymocyte differentiation is maintained throughout chronic my-
cobacterial infection, despite the presence of a considerable
number of mycobacteria-infected cells within the thymus.
We next asked to what extent the newly generated T cells, whose
differentiation occurred within infected thymi, were able to mount
a protective immune response against mycobacterial infections. To
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characterize T cells whose differentiation occurred within infected
thymi and their ability to control mycobacteria growth, it was
necessary to create a system in which these cells could be analyzed
with no interference from T lymphocytes whose differentiation
occurred prior to thymic infection. To do so, thymic lobes fromM.
avium-infected TCRa2/2 mice (28) were transplanted under the
kidney capsule of athymic nude mice. Nude mice have no thymus
but have competent T cell precursors (29), and TCRa2/2 mice
have a thymus, but their T cell precursors are unable to fully
differentiate (28). By performing these thymic transplants, we
generated mice with T cells derived from nude mice’s bone
marrow that differentiated exclusively within M. avium-infected
TCRa2/2 thymi (Fig. 3A). Nude mice transplanted with non-
infected thymi were used as controls. Most bacteria within the
infected transplanted thymi (containing ∼105–6 CFU) seemed to
remain within the thymus, because we were only able to detect
a low number of bacteria in other organs in a few transplanted
animals (three of eight) 4–8 wk posttransplantation (data not
shown). However, even if residual, these could contribute to pe-
ripheral T cell response when posterior infection is induced.
Therefore, to guarantee that a similar bacterial load was present in
the peripheral organs of nude mice transplanted with infected or
noninfected thymi at the moment of peripheral T cell colonization,
all animals were infected 3 d postthymic transplantation (i.v. in-
fection with 106 CFU) (Fig. 3A). At 5 wk posttransplantation,
similar numbers of newly formed CD4+CD3+ and CD8+CD3+
T cells were detected in the blood of mice transplanted with in-
fected or noninfected thymi (Fig. 3B). At sacrifice (7–9 wk
FIGURE 1. Identification ofM. avium-infected cells in the thymus. A, Representative kinetics ofM. avium bacterial load in the spleen, liver, and thymus.
Each point represents the mean 6 SD CFU from six mice/group for one of four experiments. B–E, Representative thymic sections from M. avium-infected
WT mice (20–24 wk postinfection) stained with Abs specific for CD11c (B–E), F4/80 (B and C), K5 (D), and K8 (E). Bacilli were detected with anti-
mycobacteria Ab (B and C) or by auramine-rhodamine staining (D and E). B, Bacteria (green) were mainly found within CD11c+ (blue) F4/80+ (red) cells.
C, Bacteria also were detected within CD11c+F4/802 cells. D and E, CD11c+ cells (blue) containing bacteria (red) surrounded by K5+ (D) and K8+ (E) cells
(green). Bar = 20 mm.
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postinfection, depending on the experiment), thymic engraftments
under the kidney capsule were confirmed macroscopically and
microscopically for each animal. The numbers of T cells in the
spleen were similar for mice transplanted with infected or non-
infected thymi (Fig. 3C). Moreover, we found no differences in
the activation profile of the T cells or in the proportion of effector/
regulatory CD4+ T cells (data not shown). Thus, T cells arising
from infected or noninfected thymi were equally able to colonize
the periphery of nude recipient mice. However, when the bacterial
load was assessed, mice transplanted with noninfected thymi
presented almost ten times fewer viable bacteria in the liver and
spleen than those transplanted with infected thymi (Fig. 3D). In-
terestingly, the bacterial load in the liver of animals transplanted
with infected thymi was not different from that found in nude
mice. These observations clearly indicate that T cells that differ-
entiate within infected thymi have an impaired ability to protect
against the same pathogen in peripheral organs.
T cells that differentiate in an infected thymus have a reduced
ability to produce IFN-g in response to M. avium Ags
The impaired ability of T cells arising from infected thymi to mount
a protective immune response against M. avium could be due to
a general defect of these cells to respond to stimuli or due to
a specific M. avium-induced tolerance. Because the immune re-
sponse against mycobacterial infections depends greatly on the
ability of mycobacteria-specific T cells to produce IFN-g (16),
splenocytes were stimulated in vitro (Fig. 4A) with a panel of M.
avium antigenic fractions (Supplemental Fig. 1). Splenocytes from
WT, as well as from nude mice transplanted with noninfected
thymi, produced similar amounts of IFN-g upon stimulation with
Con A or with M. avium antigenic fractions (Fig. 4A). In contrast,
splenocytes from mice transplanted with infected thymi generated
undetectable levels of IFN-g in response to most of the M. avium
antigenic fractions. As expected, splenocytes from non-
transplanted nude mice did not produce detectable levels of IFN-g
(data not shown). In our thymic transplant system, an innate im-
mune response to infection is taking place when de novo gener-
ated T cells colonize the periphery. Although the results suggest
that thymic export from infected and noninfected thymi is similar
(as shown by no premature thymic atrophy and no differences on
the amounts of TRECs in the thymus of infected versus non-
infected mice and by similar peripheral T cell reconstitution in
mice transplanted with infected or noninfected thymi), we cannot
exclude the possibility that a difference in the timing of thymic
export exists, which could delay the acquired immune response in
one of the experimental groups. To clarify this aspect, purified
CD4+ T cells from mice transplanted for 9 wk were transferred to
new TCRa2/2 mice (Fig. 4B). These mice were infected 3 d after
the adoptive transfer and sacrificed 18 wk later. T cells transferred
from both types of mice reconstituted equally well the periphery
of TCRa2/2mice (Supplemental Fig. 3). When stimulated in vitro
with M. avium Ags, splenocytes from mice that received CD4+
T cells from nude mice transplanted with infected thymi produced
extremely low levels of IFN-g compared with mice that received
CD4+ T cells from animals transplanted with noninfected thymi
(Fig. 4C). Further supporting the hypothesis that T cells differ-
entiating in infected thymi are specifically impaired in their ability
to respond to mycobacterial Ags was the observation that OVA-
immunized mice transplanted with infected thymi mounted an
immune response to OVA indistinguishable from that of OVA-
immunized mice transplanted with noninfected thymi (Fig. 5). It is
important to stress that because a minute amount of bacteria from
the infected thymi may disseminate to peripheral organs in some
animals, as reported previously, all animals were infected 3 d after
thymic transplant; the immunization regimen was initiated at 3 wk
posttransplant.
Differentiation within infected thymi generates T cells unable
to participate in the formation of organized granulomas
Although Ag-specific T cells are required for the formation of fully
mature granulomas, only poorly organized granulomas are observed
in T cell-deficient hosts, provided that there is IFN-g secretion by
innate immune cells (30). The liver inflammatory lesions of nude
mice transplanted with infected or noninfected thymi, as well as the
nontransplanted nude and WT mice, were classified, taking into
consideration their organization as nonorganized infiltrates (lym-
phocytes and/or macrophage-like cells showing no signs of orga-
nization), poorly organized granulomas (a central core of
macrophage-like cells surrounded by lymphocytes but not forming
a clear cuff), and well-organized granulomas (a central core of
macrophage-like cells surrounded by a well-defined cuff of lym-
phocytes) (Fig. 6A, right, middle, and left panels, respectively).
Although the three types of lesions were present in the liver of WT
infected animals, well-organized granulomas, which depend on the
existence of Ag-specific T cells, were virtually absent from nude
mice, as described previously (30). Mice transplanted with infected
FIGURE 2. M. avium infection of the thymus does not lead to premature thymic atrophy but causes minor changes in cell populations at late time points.
A, Number of thymocytes in infected and age-matched control mice. B, The percentage of the four main thymic populations (accordingly to the expression
of CD4, CD8, and CD3) in infected and age-matched control animals at different time points postinfection. pp# 0.05; ppp# 0.005. C, TCR rearrangement
in thymi assessed by the relative quantification of TREC. Each bar represents the average 6 SD of the number (A) and percentage (B) of cells or relative
amount of TREC (C) from three to six mice per group.
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thymi presented the same pattern of lesions as nude animals (Fig.
6B). These observations corroborate the finding that T cells arising
from infected thymi are mostly depleted of activated mycobacteria-
specific T cells. The inability of T cells frommice transplanted with
infected thymi to participate in the formation of structured granu-
lomas is further supported by the lower number of liver lesions
expressing iNOS, an enzyme whose expression is upregulated in
activated macrophages (12), compared with WT or mice trans-
planted with noninfected thymi (Fig. 6C, 6D).
Discussion
This study shows that thymi infected with M. avium retain the
ability to generate new T cells. However, T cells generated within
infected thymi are unable to mount a protective response against
M. avium in the periphery. This raises the possibility of a defect in
the T cells generated within infected thymi. The similarities in the
ability of infected and noninfected thymi (or of isolated T cells
recovered from transplanted recipients) to repopulate the periph-
ery, as well as their indistinguishable ability to produce IFN-g in
response to Con A, strongly argue against a general defect of the
T cells generated within infected thymi. Moreover, the observation
that T cells that differentiate within infected thymi mount an
immune response to OVA that is similar to that of T cells that
differentiate in noninfected thymi shows that, in both cases,
T cells are able to mount T cell-specific immune responses.
Therefore, the T cell tolerance observed against M. avium Ags in
animals transplanted with infected thymi seems specific to this
pathogen, as evaluated by their inability to control bacterial
growth and their reduced aptitude to produce IFN-g upon stimu-
lation with a set of mycobacterial Ags. These results show that
T cells generated in infected thymi are specifically impaired in
their ability to respond to M. avium Ags.
Because mycobacteria were detected within macrophages and DCs
in the medulla and at the cortico-medullary region and that DCs are
recognized key players in the clonal deletion of specific T cells (22, 26,
31), the clonal deletion ofM. avium–specific T cells is the most likely
FIGURE 3. Tcellswhosedifferentiation takesplacewithin infected thymipresent an impairedability tofight thepathogen inperipheral organs.A,Thymic lobes from
TCRa2/2micewere transplanted under the kidney capsule of nude mice (thymic donors were animals previously infected withM. avium or age-matched noninfected
controls). Transplantedmicewere infectedwithM. avium 3 d after surgery and sacrificed 9wk later.B, Representative plots of the CD4 andCD8 staining in the blood at
different timepointsafter transplantationwithnoninfected (upperpanels) or infected (lowerpanels) thymic lobes.WT(left upperpanel) andnude (left lowerpanel) blood
cells are also depicted.C, Number ofCD4+T cells andCD8+T cells in the spleen.D, Bacterial loadswere assessed in liver and spleen 9wk after infection. Each column
represents the mean6 SD of the numbers of cells (C) or the CFU (D) from three to seven mice per group from one of three experiments. pp# 0.05; pppp# 0.001.
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mechanism responsible for the observed M. avium tolerance. It was
recently shown that adoptively transferred DCs loaded with a nonself
Ag migrate to the thymus, leading to clonal deletion of T cells that
recognize thatAg (23), and thatwithin the thymus,DCsof extrathymic
origin are mainly localized at the cortico-medullary region (32).
Because regulatory T cells participate in the immune response
against mycobacteria (33), the possibility that differentiation within
infected thymi alters the generation of regulatory T cells, leading to
the differentiation of a T cell population enriched in regulatory
T cells or particularly enriched in mycobacteria-specific regulatory
T cells, should also be taken into consideration. This is particularly
relevant because of the recent data that associateDCs of extrathymic
origin with the generation of regulatory T cells within the thymus
(24). Although infected DCs are detected within the thymus, our
results do not support the possibility that regulatory T cells are re-
sponsible for the decreased protection against M. avium. Mice that
were transplanted with infected thymi did not present more regu-
latory T cells in the periphery, either in absolute numbers or in the
proportion of regulatory/effector CD4+ T cells. Effector and regu-
latory Ag-specific T cells located in the infected tissues were shown
initially for Leishmania major infection (34); more recently, it was
reported that regulatory T cells do participate in the formation of
mycobacteria-induced granulomas (33). Thus, our observation that
the pattern of inflammatory lesions is similar in nude mice that were
and were not transplanted with infected thymi strongly suggests the
lack ofM. avium-specific T cells, whether regulatory or effector, in
animals transplanted with infected thymi.
Although infection of the thymus has previously attracted the
curiosity of researchers, to the best of our knowledge, this study is
FIGURE 4. T cells differentiated within infected thymi show impaired ability to produce IFN-g in response toM. aviumAgs. A, Splenocytes fromWTand nude
mice transplantedwith noninfected or infected thymi (right,middle, and left panels, respectively)were stimulated invitrowithConA,M. avium total extract (referred
to asM. avium in the figure), and a panel of antigenic fractions prepared from the supernatant of theM. avium culture (Fr1 to Fr20) (details on the preparation can be
found in Supplemental Fig. 1). IFN-g was quantified in the cell supernatants by ELISA. B, Thymic lobes from TCRa2/2 infected or noninfected mice were
transplanted under the kidney capsule of nude recipientmice. Transplantedmicewere infected 3 d later withM. avium and sacrificed after 9wk. PurifiedCD4+T cells
from thesemicewere adoptively transferred to TCRa2/2mice that were infectedwithM. avium 3 d later and sacrificed 18wk afterward.C, Splenocytes of TCRa2/2
mice adoptively transferredwithCD4+Tcells fromnudemice transplantedwith noninfected (left panel) or infected thymi (right panel)were stimulatedwith the same
Ags described in A. Each bar represents the mean6 SD of the IFN-g concentration from three to six mice per group from one of three independent experiments.
FIGURE 5. Upon immunization, T cells that differentiated within infected
thymi respond in vitro to OVA. Nude mice transplanted with infected or non-
infected thymic lobes fromTCRa2/2micewere infected, immunizedwithOVA,
and sacrificed1wkafter the last immunization.Thenumber of IFN-g–producing
splenocytes, when stimulated with Ag85 (left panel) or with OVA (right panel),
was assessed byELISPOT. Each bar represents themean6SDof the number of
IFN-g–producing cells from four to five mice per group. pp# 0.05.
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the first demonstration that bacteria within the thymus lead to the
generation of T cells that are impaired in their ability to mount
a protective immune response against the infecting pathogen in the
periphery. The fact that the newly generated T cells are, to a great
extent, tolerant toM. avium raises new questions for understanding
the host–parasite interaction during chronic persistent infections.
One needs to consider the hypotheses that this induced-tolerance
on de novo generated T cells may represent an advantage or
a disadvantage for the host. In fact, the process might be part of
a broader mechanism that prevents excessive immune response
and, consequently, immunopathology. It should be noted that in
immune-competent animals, newly generated T cells are not
necessary to control a persistent infection, because mycobacterial
growth in mice thymectomized 2 wk prior to infection is the same
as that of sham-thymectomized mice [data not shown and (12,
35)]. However, this might also be detrimental, especially in sit-
uations in which the peripheral T cell population depends to
a great extent on thymic export, as we showed in this study. In
humans, despite the progressive physiologic thymic atrophy ob-
served with age, it is becoming clear that the thymus maintains its
ability to generate new T cells in adulthood (36, 37). This is of
relevance in situations of T cell reconstitution upon severe lym-
phopenia, such as in patients with AIDS (37) and those submitted
to cytoreductive transplant (38) or receiving chemotherapy (39).
After autologous transplant, thymopoiesis has been shown to be
critical to restore the peripheral CD4+ T cell population. This
recovery encompasses the reconstitution of CD4+ T cells ex-
pressing a diverse TCR repertoire (36). Moreover, for HIV+ pa-
tients receiving highly active antiretroviral therapy, thymic
volume increase was associated with better CD4+ T cell recovery
(37). The data presented in this study suggest that, when the pe-
ripheral T cell population reconstitution depends greatly on de
novo thymic export, infection of the thymus by mycobacteria may
have, in humans, a relevant negative effect on the ability to control
chronic slow-progressing or latent infections.
In summary, our observations show that during infection with
M. avium, infected cells within the thymus induce tolerance spe-
cifically to mycobacterial Ags. This is the first report showing in-
duced central tolerance to an infecting pathogen. Knowing that the
thymus is also a target organ formycobacterial infections in humans,
it is now important to evaluate to what extent the newly generated
T cells from patients infected with M. avium or M. tuberculosis
display an impaired ability to respond to mycobacterial Ags.
Acknowledgments
We thank Drs. Christophe Benoist, Maria de Sousa, and Paulo Vieira for
encouraging discussions and critical reading of the manuscript and Javier
Moreno for technical assistance.
Disclosures
The authors have no financial conflicts of interest.
References
1. Cosma, C. L., D. R. Sherman, and L. Ramakrishnan. 2003. The secret lives of
the pathogenic mycobacteria. Annu. Rev. Microbiol. 57: 641–676.
2. Cooper, A. M. 2009. Cell-mediated immune responses in tuberculosis. Annu.
Rev. Immunol. 27: 393–422.
3. Kirk, O., J. M. Gatell, A. Mocroft, C. Pedersen, R. Proenca, R. P. Brettle,
S. E. Barton, P. Sudre, and A. N. Phillips. 2000. Infections with Mycobacterium
tuberculosis and Mycobacterium avium among HIV-infected patients after the
introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
Am. J. Respir. Crit. Care Med. 162: 865–872.
4. Wagner, D., and L. S. Young. 2004. Nontuberculous mycobacterial infections:
a clinical review. Infection 32: 257–270.
5. Ganesan, S., and K. Ganesan. 2008. Multilocular thymic tuberculosis: case re-
port. Br. J. Radiol. 81: e127–e129.
6. Sacco, O., C. Gambini, M. Aicardi, M. Silvestri, U. G. Rossi, P. Toma`,
G. Mattioli, V. Jasonni, and G. A. Rossi. 2004. Thymus tuberculosis poorly
responding to anti-mycobacterial therapy in a young girl with primary infection.
Sarcoidosis Vasc. Diffuse Lung Dis. 21: 232–236.
7. Stephen, T., R. Thankachen, B. Parihar, S. Nair, and V. Shukla. 2003. Multi-
locular tuberculous cyst of thymus gland. J. Thorac. Cardiovasc. Surg. 126:
2093–2094.
8. Simmers, T. A., C. Jie, and M. C. Sie. 1997. Thymic tuberculosis: a case report.
Neth. J. Med. 51: 87–90.
9. FitzGerald, J. M., J. R. Mayo, R. R. Miller, W. R. Jamieson, and F. Baumgartner.
1992. Tuberculosis of the thymus. Chest 102: 1604–1605.
10. Nobrega, C., P. J. Cardona, S. Roque, P. Pinto do O, R. Appelberg, and
M. Correia-Neves. 2007. The thymus as a target for mycobacterial infections.
Microbes Infect. 9: 1521–1529.
FIGURE 6. T cells differentiated in infected thymi do not participate in the formation of well-organized granulomas. Liver sections from mice trans-
planted with infected or noninfected thymic lobes (as described in Fig. 2) and control mice were analyzed 9 wk posttransplant. A, Representative he-
matoxylin and eosin staining showing three types of hepatic lesions. B, The percentage of each type of lesion was assessed. C, Percentage of iNOS+ lesions
in the liver. Each bar represents the mean6 SD from five to nine mice per group. D, Representative iNOS staining of liver lesions from WT, nude, and nude
mice transplanted with infected or noninfected thymic lobes. Bar = 50 mm (original magnification 3200). pp # 0.05; ppp # 0.005; pppp # 0.001.
The Journal of Immunology 357
11. Savino, W. 2006. The thymus is a common target organ in infectious diseases.
PLoS Pathog. 2: e62.
12. Flo´rido, M., A. S. Gonc¸alves, R. A. Silva, S. Ehlers, A. M. Cooper, and
R. Appelberg. 1999. Resistance of virulent Mycobacterium avium to g in-
terferon-mediated antimicrobial activity suggests additional signals for induction
of mycobacteriostasis. Infect. Immun. 67: 3610–3618.
13. Brandt, L., M. Elhay, I. Rosenkrands, E. B. Lindblad, and P. Andersen. 2000.
ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect. Immun.
68: 791–795.
14. Khader, S. A., G. K. Bell, J. E. Pearl, J. J. Fountain, J. Rangel-Moreno,
G. E. Cilley, F. Shen, S. M. Eaton, S. L. Gaffen, S. L. Swain, et al. 2007. IL-23
and IL-17 in the establishment of protective pulmonary CD4+ T cell responses
after vaccination and during Mycobacterium tuberculosis challenge. Nat. Im-
munol. 8: 369–377.
15. Broers, A. E., J. P. Meijerink, J. J. van Dongen, S. J. Posthumus, B. Lo¨wenberg,
E. Braakman, and J. J. Cornelissen. 2002. Quantification of newly developed
T cells in mice by real-time quantitative PCR of T-cell receptor rearrangement
excision circles. Exp. Hematol. 30: 745–750.
16. Pais, T. F., J. F. Cunha, and R. Appelberg. 2000. Antigen specificity of T-cell
response to Mycobacterium avium infection in mice. Infect. Immun. 68: 4805–
4810.
17. Kariyone, A., K. Higuchi, S. Yamamoto, A. Nagasaka-Kametaka, M. Harada,
A. Takahashi, N. Harada, K. Ogasawara, and K. Takatsu. 1999. Identification of
amino acid residues of the T-cell epitope of Mycobacterium tuberculosis a an-
tigen critical for Vbeta11(+) Th1 cells. Infect. Immun. 67: 4312–4319.
18. Klug, D. B., C. Carter, E. Crouch, D. Roop, C. J. Conti, and E. R. Richie. 1998.
Interdependence of cortical thymic epithelial cell differentiation and T-lineage
commitment. Proc. Natl. Acad. Sci. USA 95: 11822–11827.
19. Gonzalez-Juarrero, M., T. S. Shim, A. Kipnis, A. P. Junqueira-Kipnis, and
I. M. Orme. 2003. Dynamics of macrophage cell populations during murine
pulmonary tuberculosis. J. Immunol. 171: 3128–3135.
20. Sko¨ld, M., and S. M. Behar. 2008. Tuberculosis triggers a tissue-dependent
program of differentiation and acquisition of effector functions by circulating
monocytes. J. Immunol. 181: 6349–6360.
21. Ulrichs, T., M. Lefmann, M. Reich, L. Morawietz, A. Roth, V. Brinkmann,
G. A. Kosmiadi, P. Seiler, P. Aichele, H. Hahn, et al. 2005. Modified im-
munohistological staining allows detection of Ziehl-Neelsen-negative Myco-
bacterium tuberculosis organisms and their precise localization in human tissue.
J. Pathol. 205: 633–640.
22. Matzinger, P., and S. Guerder. 1989. Does T-cell tolerance require a dedicated
antigen-presenting cell? Nature 338: 74–76.
23. Bonasio, R., M. L. Scimone, P. Schaerli, N. Grabie, A. H. Lichtman, and
U. H. von Andrian. 2006. Clonal deletion of thymocytes by circulating dendritic
cells homing to the thymus. Nat. Immunol. 7: 1092–1100.
24. Proietto, A. I., S. van Dommelen, P. Zhou, A. Rizzitelli, A. D’Amico,
R. J. Steptoe, S. H. Naik, M. H. Lahoud, Y. Liu, P. Zheng, et al. 2008. Dendritic
cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad.
Sci. USA 105: 19869–19874.
25. Mathis, D., and C. Benoist. 2009. Aire. Annu. Rev. Immunol. 27: 287–312.
26. Gallegos, A. M., and M. J. Bevan. 2004. Central tolerance to tissue-specific
antigens mediated by direct and indirect antigen presentation. J. Exp. Med. 200:
1039–1049.
27. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kosek, J. M. McCune, and
H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature 363: 728–
732.
28. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara,
J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, et al. 1992.
Mutations in T-cell antigen receptor genes a and b block thymocyte de-
velopment at different stages. Nature 360: 225–231.
29. Wortis, H. H., S. Nehlsen, and J. J. Owen. 1971. Abnormal development of the
thymus in “nude” mice. J. Exp. Med. 134: 681–692.
30. Thomsen, B. V., E. M. Steadham, J. M. Gallup, M. R. Ackermann, D. J. Brees,
and N. F. Cheville. 2001. T cell-dependent inducible nitric oxide synthase pro-
duction and ultrastructural morphology in BALB/c mice infected with Myco-
bacterium avium subspecies paratuberculosis. J. Comp. Pathol. 125: 137–144.
31. Kyewski, B., and L. Klein. 2006. A central role for central tolerance. Annu. Rev.
Immunol. 24: 571–606.
32. Li, J., J. Park, D. Foss, and I. Goldschneider. 2009. Thymus-homing peripheral
dendritic cells constitute two of the three major subsets of dendritic cells in the
steady-state thymus. J. Exp. Med. 206: 607–622.
33. Scott-Browne, J. P., S. Shafiani, G. Tucker-Heard, K. Ishida-Tsubota,
J. D. Fontenot, A. Y. Rudensky, M. J. Bevan, and K. B. Urdahl. 2007. Expansion
and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp.
Med. 204: 2159–2169.
34. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002.
CD4+CD25+ regulatory T cells control Leishmania major persistence and im-
munity. Nature 420: 502–507.
35. Winslow, G. M., A. D. Roberts, M. A. Blackman, and D. L. Woodland. 2003.
Persistence and turnover of antigen-specific CD4 T cells during chronic tuber-
culosis infection in the mouse. J. Immunol. 170: 2046–2052.
36. Hakim, F. T., S. A. Memon, R. Cepeda, E. C. Jones, C. K. Chow, C. Kasten-
Sportes, J. Odom, B. A. Vance, B. L. Christensen, C. L. Mackall, et al. 2005.
Age-dependent incidence, time course, and consequences of thymic renewal in
adults. J. Clin. Invest. 115: 930–939.
37. Ho Tsong Fang, R., A. D. Colantonio, and C. H. Uittenbogaart. 2008. The role of
the thymus in HIV infection: a 10 year perspective. AIDS 22: 171–184.
38. Williams, K. M., F. T. Hakim, and R. E. Gress. 2007. T cell immune re-
constitution following lymphodepletion. Semin. Immunol. 19: 318–330.
39. Sfikakis, P. P., G. M. Gourgoulis, L. A. Moulopoulos, G. Kouvatseas,
A. N. Theofilopoulos, and M. A. Dimopoulos. 2005. Age-related thymic activity
in adults following chemotherapy-induced lymphopenia. Eur. J. Clin. Invest. 35:
380–387.
358 THYMIC INFECTION BY MYCOBACTERIA
